Skip to main content

memo - Magazine of European Medical Oncology

Ausgabe 2/2022

Inhalt (20 Artikel)


ESMO 2021

Rupert Bartsch


COVID-19 crisis and cancer

Rupert Bartsch, Wolfgang Hilbe


Highlights ESMO 2021—lung cancer

Markus Rauter

Open Access short review

ESMO 2021—my top three abstracts in breast cancer

Christoph Suppan

Open Access short review

ESMO 2021—highlights in colorectal cancer

Lukas Weiss

short review

Breast Cancer—Essential news of current guidelines

Kathrin Strasser-Weippl

Open Access short review

Antibody–drug conjugates—the magic bullet?

Marie-Bernadette Aretin

short review

New targeted therapies in kidney cancer

Karl Mayrhofer, Dora Niedersüß-Beke

Open Access short review

Tracking mutation and drug-driven alterations of oncokinase conformations

Andreas Feichtner, Valentina Kugler, Selina Schwaighofer, Thomas Nuener, Jakob Fleischmann, Eduard Stefan

case report

Systemic capillary leak syndrome following granulocyte colony-stimulating factor therapy in a T-lymphoblastic leukemia/lymphoma patient: a case report

Ahmed H. Al Sharie, Yazan O. Al Zu’bi, Sarah Al Sharie, Hawra A. Baydoun, Farah H. Atawneh, Osama Alshari, Dima Albals

original report

High mortality in patients with active malignancy and severe COVID-19

Simon Udovica, Nino Müser, Agnes Pechlaner, Andreas Reichinger, Christoph Aichinger, Kathrin Strasser-Weippl, Holger Rumpold, Andreas Petzer, Ewald Wöll, Wolfgang Hilbe, Ercan Müldür

case report

Neurotoxicity as a rare side effect of immune checkpoint inhibitors. A case report and review of the literature

Simon Udovica, Kathrin Strasser-Weippl, Eva Fischer, Dora Niedersüß-Beke

case report

Immunotherapy pitfall: sarcoid-like reaction mimicking disease progression in advanced melanoma treated with nivolumab

Beatrix Mutschlechner, Susanne Dertinger, Felix Offner, Veronika Buck, Alexander Becherer, Klaus Gasser, Bernd Hartmann, Thomas Winder

Aktuelle Ausgaben